Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 5S ribosomal pseudogene 19 is a non-coding RNA locus classified as a processed pseudogene of the 5S ribosomal RNA gene family. Pseudogenes are gene sequences similar to functional genes but contain mutations or deletions that prevent them from being expressed as functional molecules. The canonical 5S ribosomal RNA is a highly conserved, functional component of the large ribosomal subunit, critical for ribosome assembly and protein synthesis[1][7][4][9]. In contrast, pseudogene copies, like RNA5SP19, are typically non-functional and not involved in ribosome biology or therapeutic targeting[2][8][10]. Some ribosomal RNA pseudogenes may be transcribed and play regulatory roles or be processed into small RNAs, but there is no evidence that RNA5SP19 has such activities. Thus, RNA5SP19 is not a therapeutic target and should not be considered in drug discovery or biomarker strategies.
Not applicable; as a pseudogene, it is not targeted therapeutically and has no known mechanism of action in drug targeting.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 5S ribosomal pseudogene 19 (RNA5SP19).